BlackRock’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Sell |
3,766,658
-116,842
| -3% | -$687K | ﹤0.01% | 2918 |
|
|
2025
Q1 | $32.6M | Buy |
3,883,500
+109,402
| +3% | +$918K | ﹤0.01% | 2601 |
|
|
2024
Q4 | $28.1M | Sell |
3,774,098
-408,222
| -10% | -$3.04M | ﹤0.01% | 2785 |
|
|
2024
Q3 | $24.3M | Buy |
4,182,320
+113,654
| +3% | +$659K | ﹤0.01% | 2863 |
|
|
2024
Q2 | $27.1M | Buy |
4,068,666
+368,470
| +10% | +$2.45M | ﹤0.01% | 2756 |
|
|
2024
Q1 | $48.3M | Buy |
3,700,196
+8,295
| +0.2% | +$108K | ﹤0.01% | 2409 |
|
|
2023
Q4 | $47.1M | Buy |
3,691,901
+234,599
| +7% | +$2.99M | ﹤0.01% | 2465 |
|
|
2023
Q3 | $45.3M | Buy |
3,457,302
+336,752
| +11% | +$4.41M | ﹤0.01% | 2413 |
|
|
2023
Q2 | $79.8M | Buy |
3,120,550
+525,466
| +20% | +$13.4M | ﹤0.01% | 2168 |
|
|
2023
Q1 | $65.4M | Buy |
2,595,084
+231,028
| +10% | +$5.82M | ﹤0.01% | 2249 |
|
|
2022
Q4 | $54.3M | Buy |
2,364,056
+95,145
| +4% | +$2.19M | ﹤0.01% | 2380 |
|
|
2022
Q3 | $50.1M | Buy |
2,268,911
+425,350
| +23% | +$9.39M | ﹤0.01% | 2405 |
|
|
2022
Q2 | $26.4M | Buy |
1,843,561
+238,372
| +15% | +$3.42M | ﹤0.01% | 2876 |
|
|
2022
Q1 | $30.4M | Buy |
1,605,189
+86,363
| +6% | +$1.63M | ﹤0.01% | 2848 |
|
|
2021
Q4 | $28.3M | Buy |
1,518,826
+832,591
| +121% | +$15.5M | ﹤0.01% | 2996 |
|
|
2021
Q3 | $18.5M | Buy |
686,235
+3,894
| +0.6% | +$105K | ﹤0.01% | 3279 |
|
|
2021
Q2 | $21.3M | Buy |
+682,341
| New | +$21.3M | ﹤0.01% | 3201 |
|